导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.33% | 831/1050 |
| 近一周 | -4.21% | 1002/1104 |
| 近一月 | -9.28% | 1008/1102 |
| 近一季 | -10.03% | 663/1092 |
| 近半年 | -8.91% | 735/1070 |
| 近一年 | -10.82% | 752/1018 |
| 近两年 | 77.18% | 310/926 |
| 近三年 | 21.25% | 476/834 |
| 成立以来 | 48.87% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.98% 817/1070 |
4.99% 619/1101 |
- - |
- - |
| 2025 | 52.70% 166/1065 |
24.21% 13/1014 |
-1.37% 807/1038 |
36.61% 253/1050 |
-8.77% 852/1065 |
| 2024 | 0.51% 567/1011 |
-14.43% 901/960 |
-4.47% 603/983 |
22.30% 42/991 |
0.54% 291/1011 |
| 2023 | -22.20% 731/952 |
1.56% 536/880 |
-2.57% 341/895 |
-12.69% 710/915 |
-9.95% 856/952 |
| 2022 | -10.96% 96/867 |
-18.92% 465/773 |
13.92% 149/806 |
-9.45% 211/845 |
6.45% 150/867 |
| 2021 | 7.34% 274/740 |
5.59% 44/580 |
6.06% 448/659 |
-8.87% 475/704 |
5.18% 215/740 |
| 2020 | 20.34% 380/554 |
-8.96% 368/419 |
15.12% 349/466 |
5.63% 354/517 |
8.70% 381/554 |
| 2019 | - - |
- - |
-0.10% 352/1231 |
1.73% 283/390 |
7.62% 254/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实互通精选股票 VS. 东吴新产业精选股票A(580008) |